REFILE-XENON PHARMACEUTICALS SHARES FALL 27.5% PREMARKET AFTER CO PAUSES NEW ENROLLMENT IN DEPRESSION DRUG TRIALS (FIXES TYPO IN SHARE PRICE)

Reuters · 2d ago

Please log in to view news